What’s that on Tim’s wrist? Apple CEO Tim Cook has been wearing – and talking about – a prototype wristworn glucometer, according to a report in CNBC. Cook spoke to some students at the University of Glasgow about the device, but the company hasn’t shared any details. A rumor surfaced last month that Apple is working on a wrist sensor for blood glucose, which would be something of a gamechanger in the continuous glucose monitoring space.
FDA digital health plans in progress. Wired magazine spoke with Bakul Patel, the associate center director for digital health at the FDA, about the agency’s plans to create a digital health center. While the FDA’s plans have been known for a while, the piece confirms that the Trump administration has not interfered with the plans.
Lumo shares efficacy data from AI coach. Lumo study Wearable tracker company Lumo Bodytech released new data about its AI-powered coach Lumo Run. In an eight-month dataset containing more than 27,000 runs, the company found that 97 percent of users improved their running form in the first three runs. Additionally, 82 percent of men and 76 percent of women improved in distance and/or pace using the tool.
Cardiac monitoring meets activity tracking. PocketECG, a mobile cardiac telemetry system made by Polish company Medicalgorithmics, will add an activity tracking feature, the company announced last week at a Heart Rhythm Society event in Chicago. PocketECG is an FDA-cleared system worn by the patient for 30 days to help doctors diagnose cardiac conditions. The addition of an activity monitor will help put heart readings into context and distinguish between heart rate changes caused by activity changes and those caused by an arrhythmia.
One Drop, many subscription packages. New York City-based diabetes management company One Drop announced a slew of new subscription options for its customers in the United States, the UK, and the EU yesterday. This includes standalone subscriptions to One Drop Experts, the company’s coaching service. You can see the whole range of new options here.
EarlySense updates platform. Israeli connected patient monitoring company EarlySense announced a major update to its software platform. “The update unifies EarlySense’s solutions for the continuum of care into one software suite, providing seamless interoperability between locations within a facility, or monitoring of patients in a variety of settings,” the company explained in a release. “This allows facilities to easily manage and extend continuous monitoring capabilities to additional locations.” The update also brings the software inline with ECRI patient safety guidelines for detection and monitoring of patients on opioids.
